Aluminum inclusion macrophagic myofasciitis: a recently identified condition

Immunol Allergy Clin North Am. 2003 Nov;23(4):699-712. doi: 10.1016/s0889-8561(03)00095-x.

Abstract

The authors conclude that the persistence of aluminum hydroxide at the site of intramuscular injection is a novel finding which has an exact significance that remains to be established fully. It seems mandatory to evaluate possible long-term adverse effects induced by this compound, because this issue has not been addressed (in the past, aluminum hydroxide was believed to be cleared quickly from the body). If safety concerns about the long-term effects of aluminum hydroxide are confirmed, novel and alternative vaccine adjuvants to rescue vaccine-based strategies should be proposed to ensure the enormous benefit for public health that these vaccines provide worldwide.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Aluminum Hydroxide / adverse effects*
  • Aluminum Hydroxide / immunology
  • Fatigue Syndrome, Chronic / chemically induced
  • Fatigue Syndrome, Chronic / immunology*
  • Female
  • Humans
  • Macrophages / immunology*
  • Male
  • Middle Aged
  • Myositis, Inclusion Body / chemically induced
  • Myositis, Inclusion Body / immunology*
  • Myositis, Inclusion Body / physiopathology
  • Pharmaceutic Aids / adverse effects*
  • Vaccines / adverse effects*

Substances

  • Pharmaceutic Aids
  • Vaccines
  • Aluminum Hydroxide